Chimerix, Inc. (CMRX)
NASDAQ: CMRX · Real-Time Price · USD
0.940
+0.060 (6.77%)
Nov 21, 2024, 12:09 PM EST - Market open

Chimerix Revenue

Chimerix had revenue of $26.00K in the quarter ending September 30, 2024, with 136.36% growth. This brings the company's revenue in the last twelve months to $159.00K, down -85.98% year-over-year. In the year 2023, Chimerix had annual revenue of $324.00K, down -99.04%.

Revenue (ttm)
$159.00K
Revenue Growth
-85.98%
P/S Ratio
n/a
Revenue / Employee
$2,208
Employees
72
Market Cap
84.50M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023324.00K-33.50M-99.04%
Dec 31, 202233.82M31.85M1,609.15%
Dec 31, 20211.98M-3.39M-63.16%
Dec 31, 20205.37M-7.15M-57.09%
Dec 31, 201912.52M5.30M73.49%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
23andMe Holding Co. 193.26M
Assertio Holdings 125.76M
OptimizeRx 88.18M
MDxHealth 84.71M
Clearside Biomedical 7.70M
Armata Pharmaceuticals 5.47M
Ikena Oncology 659.00K
Revenue Rankings